Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages

Microbes and Infection

Volumn 8, Issue 5, 2006, Pages 1194-1202

  Baize, Sylvain ^a   Pannetier, Delphine ^a   Faure, Caroline ^a   Marianneau, Philippe ^a   Marendat, Ingrid ^a   Georges Courbot, Marie Claude ^a   Deubel, Vincent ^a  

^a University Lyon i   (France)

Author keywords

Antigen presenting cell; Arenavirus; Human; Innate immunity

Indexed keywords

ALPHA2B INTERFERON; CD40 LIGAND; GAMMA INTERFERON; INTERFERON; LAMBDA INTERFERON; LIPOPOLYSACCHARIDE; RECOMBINANT INTERFERON; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LASSA FEVER; LASSA VIRUS; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; VERO CELL; VIRUS REPLICATION;

LASSA VIRUS;

EID: 33744935244     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.02.002     Document Type: Article

References (38)

1. Buckley S.M., and Casals J. Lassa fever, a new virus disease of man from West Africa. III. Isolation and characterization of the virus. Am. J. Trop. Med. Hyg. 19 (1970) 680-691
2. McCormick J.B., Webb P.A., Krebs J.W., Johnson K.M., and Smith E.S. A prospective study of the epidemiology and ecology of Lassa fever. J. Infect. Dis. 155 (1987) 437-444
3. Fisher-Hoch S.P., Tomori O., Nasidi A., Perez-Oronoz G., Fakile Y., Hutwagner L., and McCormick J.B. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. Br. Med. J. 311 (1995) 857-859
4. Lukashevich I.S., Maryankova R., Vladyko A.S., Nashkevic N., Koleda S., Djavani M., Horejsh D., Voitenok N.N., and Salvato M.S. Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF-α gene expression. J. Med. Virol. 59 (1999) 552-560
5. Mahanty S., Hutchinson K., Agarwal S., Mcrae M., Rollin P.E., and Pulendran B. Cutting Edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J. Immunol. 170 (2003) 2797-2801
6. Baize S., Kaplon J., Faure C., Pannetier D., Georges-Courbot M.C., and Deubel V. Lassa virus infection of dendritic cells and macrophages is productive but fails to activate cells. J. Immunol. 172 (2004) 2861-2869
7. Winn W.C.J., and Walker D.H. The pathology of human Lassa fever. Bull. WHO 52 (1975) 535-545
8. Johnson K.M., McCormick J.B., Webb P.A., Smith E.S., Elliott L.H., and King I.J. Clinical virology of Lassa fever in hospitalized patients. J. Infect. Dis 155 (1987) 456-463
9. Fisher-Hoch S.P., Hutwagner L., Brown B., and McCormick J.B. Effective vaccine for Lassa fever. J. Virol. 74 (2000) 6777-6783
10. ter Meulen J., Badusche M., Kuhnt K., Doetze A., Satoguina J., Marti T., Loeliger C., Koulemou K., Koivogui L., Schmitz H., Fleischer B., and Hoerauf A. Characterization of human CD4+ T cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein. J. Virol. 74 (2000) 2186-2192
11. ter Meulen J., Badusche M., Satoguina J., Strecker T., Lenz O., Loeliger C., Sakho M., Koulemou K., Koivogui L., and Hoerauf A. Old and New world arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+T-cell clones. Virology 321 (2004) 134-143
12. Edington G.M., and White H.A. The pathology of Lassa fever. Trans. R. Soc. Trop. Med. Hyg. 66 (1972) 381-389
13. Fisher-Hoch S.P., Mitchell S.W., Sasso D.R., Lange J.V., Ramsey R., and McCormick J.B. Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever. J. Infect. Dis. 155 (1987) 465-474
14. Fisher-Hoch S.P., McCormick J.B., Sasso D., and Craven R.B. Hematologic dysfunction in Lassa fever. J. Med. Virol. 26 (1988) 127-135
15. Mahanty S., Bausch D.G., Thomas R.L., Goba A., Bah A., Peters C.J., and Rollin P.E. Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. J. Infect. Dis. 183 (2001) 1713-1721
16. Pannetier D., Faure C., Georges-Courbot M.C., Deubel V., and Baize S. Human macrophages, but not dendritic cells, are activated and produce type I interferons in response to Mopeia virus infection. J. Virol. 78 (2004) 10516-10524
17. Kiley M.P., Lange J.V., and Johnson K.M. Protection of rhesus monkeys from Lassa virus by immunisation with closely related arenavirus. Lancet 2 (1979) 738-745
18. Günther S., Emmerich P., Laue T., Kühle O., Asper M., Jung A., Grewing T., Ter Meulen J., and Schmitz H. Imported Lassa fever in Germany: molecular characterization of a new Lassa virus strain. Emerg. Infect. Dis. 6 (2000) 466-476
19. Elliott L.H., McCormick J.B., and Johnson K.M. Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J. Clin. Microbiol. 16 (1982) 704-708
20. Ruo S.L., Mitchell S.W., Kiley M.P., Roumillat L.F., Fisher-Hoch S.P., and McCormick J.B. Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies. J. Gen. Virol. 72 (1991) 549-555
21. Katze M.G., He Y., and Gale Jr. M. Viruses and interferon: a fight for supremacy. Nature Rev. Immunol. 2 (2002) 675-687
22. Bose S., Kar N., Maitra R., DiDonato J.A., and Banerjee A.K. Temporal activation of NF-κB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses. Proc. Natl. Acad. Sci. USA 100 (2003) 10890-10895
23. Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes Z., Shen M., Shah N.K., Langer J.A., Sheikh F., Dickensheets H., and Donnelly R.P. IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex. Nature Immunol. 4 (2003) 69-77
24. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.-J., Pulendran B., and Palucka K. Immunobiology of dendritic cells. Ann. Rev. Immunol. 18 (2000) 767-811
25. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., and Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 (2005) 772-777
26. Conzelmann K.-K. Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses. J. Virol. 79 (2005) 5241-5248
27. Kawai T., and Akira S. Innate immune recognition of viral infection. Nature Immunol. 7 (2006) 131-137
28. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., and Liu Y.-J. The nature of the principal type 1 interferon-producing cells in human blood. Science 284 (1999) 1835-1837
29. Diebold S.S., Kaisho T., Hemmi H., Akira S., and Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 (2004) 1529-1531
30. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14 (2001) 778-809
31. Fennewald S.M., Aronson J.F., Zhang L., and Herzog N.K. Alterations in NF-κB and RBP-Jκ by arenavirus infection of macrophages in vitro and in vivo. J. Virol. 76 (2002) 1154-1162
32. Seiler P., Aichele P., Odermatt B., Hengartner H., Zinkernagel R.M., and Schwendener R.A. Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection. Eur. J. Immunol. 27 (1997) 2626-2633
33. Ou R., Zhou S., Huang L., and Moskophidis D. Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J. Virol. 75 (2001) 8407-8423
34. Asper M., Sternsdorf T., Hass M., Drosten C., Rhode A., Schmitz H., and Günther S. Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic Arenavirus. J. Virol. 78 (2004) 3162-3169
35. Takaoka A., Yanai H., Kondo S., Duncan G., Negishi H., Mizutani T., Kano S.-I., Honda K., Ohba Y., Mak T.W., and Taniguchi T. Integral role of IRF-5 in the gene induction of programme activated by toll-like receptors. Nature 434 (2005) 243-249
36. Coccia E.M., Severa M., Giacomini E., Monneron D., Remoli M.E., Julkunen I., Cella M., Lande R., and Uzé G. Viral infection and Toll-like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 34 (2004) 796-805
37. Le Bon A., and Tough D.F. Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 14 (2002) 432-436
38. Binder D., Fehr J., Hengartner H., and Zinkernagel R.M. Virus-induced transient bone marrow aplasia: major role of interferon-α/β during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J. Exp. Med. 185 (1997) 517-530